Main|Search|PHGKB
CDC’s Bring Your Brave campaign provides information about breast cancer to women younger than age 45 by sharing real stories about young women whose lives have been affected by breast cancer.
Last Posted: Jun 06, 2018
- 2018 ASCO: Neoadjuvant Use of PARP Inhibitor Shows Promise in Early-Stage, BRCA-Mutated Breast Cancer
ASCO Post, June 5, 2018 - Tailoring Chemotherapy Decisions – TAILORx Study Results
DJ Attai, Blog, June 4, 2018 - New approach to immunotherapy leads to complete response in breast cancer patient unresponsive to other treatments
NCI, June 4, 2018 - Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
JA Sparano et al, JM, June 3, 2018 - Elizabeth's breast cancer treatment didn't get in the way of her life
MSKCC, June 2018 - For Some Breast Cancer Patients, The Chemo Decision Just Got Easier
SK Watson, NPR, June 3, 2018 - Good News for Women With Breast Cancer: Many Don’t Need Chemo
D Grady, NY Times, June 2, 2018 - Many breast cancer patients can skip chemo, big study finds
M Marchionne, Stat News, June 3, 2018 - TAILORx trial finds most women with early breast cancer do not benefit from chemotherapy
NCI, June 3, 2018 - Despite risk of breast cancer, few men undergo genetic tests, study finds
E Rivero, UCLA News, May 31, 2018
.png)
No hay comentarios:
Publicar un comentario